NCT06784843 - Dexmedetomidine Versus Midazolam for Peribulbar Block | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

August 30, 2024

Study Completion Date

September 30, 2024

Conditions

Cataract

Interventions

DRUG

Dexmedetomidine as an adjuvant to local anesthesia for peribulbar block

Dexmedetomidine as an adjuvant to a local anesthetic mixture (bupivacaine, lidocaine, and hyaluronidase) for peribulbar block during cataract surgery

DRUG

Midazolam as an adjuvant to local anesthesia for peribulbar block

Midazolam as an adjuvant to a local anesthetic mixture (bupivacaine, lidocaine, and hyaluronidase) for peribulbar block during cataract surgery

Trial Locations (1)

Suez canal university, Ismailia

All Listed Sponsors

lead

Suez Canal University

OTHER